Design Therapeutics grants 30,000 stock options
Design Therapeutics, Inc. reported that director Justin D. Gover received a grant of stock options covering 30,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Design Therapeutics, Inc. reported that director Justin D. Gover received a grant of stock options covering 30,000 shares of common stock. The options have an exercise price of $10.55 per share and expire on June 8, 2036. The award vests in equal monthly installments over 12 months following June 9, 2026, and will in any case be fully vested by the date of the company’s next annual meeting of stockholders. Following this grant, Gover holds 30,000 stock options directly.
Insider Trade Summary
Grant/Award: 30,000 shares
Grant/Award
1 txn
Insider
Gover Justin D.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 30,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option vest in equal monthly installments over 12 months following June 9, 2026 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders.
Key Figures
Option grant size: 30,000 options
Exercise price: $10.55 per share
Expiration date: June 8, 2036
+3 more
6 metrics
Option grant size
30,000 options
Stock Option (right to buy) granted to Justin D. Gover
Exercise price
$10.55 per share
Conversion or exercise price of stock options
Expiration date
June 8, 2036
Option expiration for Gover’s grant
Underlying shares
30,000 shares
Common Stock underlying the option grant
Total options after grant
30,000 options
Total derivative securities following transaction
Vesting schedule
12 monthly installments
Vests over 12 months after June 9, 2026
Key Terms
Stock Option (right to buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 10.5500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-08T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"shares subject to the option vest in equal monthly installments over 12 months"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Design Therapeutics (DSGN) disclose for Justin D. Gover?
Design Therapeutics disclosed that director Justin D. Gover received a grant of stock options for 30,000 shares of common stock. The options were awarded with a transaction code “A,” indicating a grant, award, or other acquisition rather than an open-market purchase or sale.
What is the exercise price and expiration date of Justin Gover’s DSGN stock options?
Justin Gover’s stock options have an exercise price of $10.55 per share and expire on June 8, 2036. This means he may purchase Design Therapeutics common shares at $10.55 any time after vesting and before the June 8, 2036 expiration date.
How do Justin Gover’s Design Therapeutics (DSGN) options vest over time?
The options granted to Justin Gover vest in equal monthly installments over 12 months following June 9, 2026. The footnote also states the options will in any case be fully vested by the date of Design Therapeutics’ next annual meeting of stockholders, whichever occurs first.
Is Justin Gover’s DSGN stock option grant an open-market transaction?
No, the filing classifies Justin Gover’s transaction with code “A,” indicating a grant, award, or other acquisition. This reflects a compensation-related stock option grant from Design Therapeutics rather than an open-market buy or sell of existing common shares.
How many stock options does Justin Gover hold in DSGN after this grant?
After the reported transaction, Justin Gover holds 30,000 stock options directly. The Form 4 shows this as the total number of derivative securities following the transaction, all relating to options on Design Therapeutics common stock from this single reported grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
